Description

4H-Cyclopentoxazole-4,5-diol, 2-(dimethylamino)-3a,5,6,6a-tetrahydro-6-(phenylmethoxy)methyl-, dibenzoate (ester), 3aS-(3a.alpha.,4.alpha.,5.beta.,6.alpha.,6a.alpha.)- is a high-purity, complex organic intermediate with a defined stereochemistry. This compound matters as a critical building block for advanced pharmaceutical synthesis, particularly in the development of novel therapeutic agents. Research and development teams in the pharmaceutical and fine chemical industries require this material for its specific structural framework, which is essential for creating molecules with targeted biological activity.

Application

• Pharmaceutical Intermediate: Key synthetic precursor in the research and development of new active pharmaceutical ingredients (APIs).
• Medicinal Chemistry Research: Used as a scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Fine Chemical Synthesis: Serves as a specialized building block for the synthesis of complex, high-value organic molecules.
• Biochemical Research: Potential use in developing enzyme inhibitors or receptor modulators due to its specific heterocyclic and functional group architecture.
• Process Chemistry Development: Employed in route scouting and scale-up studies for the commercial production of advanced intermediates.

Basic Information

Product Name	4H-Cyclopentoxazole-4,5-diol, 2-(dimethylamino)-3a,5,6,6a-tetrahydro-6-(phenylmethoxy)methyl-, dibenzoate (ester), 3aS-(3a.alpha.,4.alpha.,5.beta.,6.alpha.,6a.alpha.)-
CAS No.	165375-31-5
Molecular Formula	C31H34N2O6
Molecular Weight	530.62 g/mol
Synonyms	2-(Dimethylamino)-3a,5,6,6a-tetrahydro-6-[(phenylmethoxy)methyl]-4H-cyclopenta[d]oxazole-4,5-diyl dibenzoate; (3aS,4R,5S,6R,6aR)-2-(Dimethylamino)-3a,5,6,6a-tetrahydro-6-[(phenylmethoxy)methyl]-4H-cyclopenta[d]oxazole-4,5-diyl dibenzoate; 4H-Cyclopenta[d]oxazole-4,5-diol, 2-(dimethylamino)-3a,5,6,6a-tetrahydro-6-[(phenylmethoxy)methyl]-, dibenzoate, (3aS,4R,5S,6R,6aR)-; 165375-31-5; Cyclopentoxazole derivative; Advanced pharmaceutical intermediate
EINECS	Contact for details

Quality Control

Our 4H-Cyclopentoxazole-4,5-diol derivative is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and chiral integrity, to ensure it meets the exacting standards required for pharmaceutical R&D. Comprehensive Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are provided with every shipment to support your quality and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This compound may be moisture-sensitive; keep the container tightly sealed in a dry environment.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Chiral Purity	≥ 98.0% ee
Single Unknown Impurity	≤ 1.0%
Total Impurities	≤ 3.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.